2025.12.23Vol.8 No.12 AI Announcement of a press release and technical white paper on the officially registered HPVM patent.
2025.12.13Vol.8 No.9 AI HPVM (AI-PV HiroPharma Validation Method): Official Licensing Program Launched
2025.12.10Vol.8 No.8 AI CIOMS “Artificial Intelligence in Pharmacovigilance (2025)” and HPVM: From Principles to Practical Implementation
2025.11.12Vol.8 No.6 AI HiroPharmaConsulting has received an official "GxP Validation Method for PV System with AI Function (Japanese Patent Application 2024-213393)" from the Japan Patent Office.
2025.09.24Vol.8 No.3 AI Reference: Yakuji Nippo News, PV: Pharmacovigilance Special Feature Interview with HiroPharmaConsulting Co., Ltd
2024.12.06Vol.7 No.2 AI HiroPharmaConsulting® Co., Ltd. will start providing the AI-PV Consulting Service in CY2025/1Q for "PV with AI: Validation Method for Pharmacovigilance System for GVP (Patent pending: Japanese Patent Application 2024-123456)."
2024.11.04Vol.6 No.19 AI Letter from the European Medicines Agency (EMA) and the Commissioner of the European Medicines Agency (HMA) regarding the use of AI-LLMs and Guiding Principles (for internal EU Regulatory Authorities).
